Company Biovica International AB (publ) Nasdaq Stockholm

Equities

SE0008613731

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Diagnostics & Testing

Inactive Instrument

Biovica International AB is a Sweden-based biotechnology company. It develops and commercializes blood-based biomarker assays for the monitoring of cancer therapies and for prediction of patient outcome. The Company has focus on breast cancer and its main product DiviTum is a blood-based test, which measures the activity of the enzyme thymidine kinase-1 (TK) in blood serum or cell cultures. The Company collaborates with numerous institutions, such as Karolinska Institutet in Sweden and Dana Farber Cancer Institute, Washington University, Baylor College of Medicine, City of Hope Research & Treatment Center in the Unites States, as well as The International Breast Cancer Study Group (IBCSG) based in Switzerland and Breast International Group in Belgium.

SEK in Million	2023	Weight	2024	Weight	Delta
Research Test 61.8 %	-	-	5	61.8 %	-
Research Kit 27.4 %	-	-	2	27.4 %	-
In Vitro Diagnostics 10.8 %	-	-	1	10.8 %	-

SEK in Million	2023	Weight	2024	Weight	Delta
United States 76.6 %	3	96.3 %	6	76.6 %	+71.36%
European Union excluding Sweden 18.8 %	0	3.7 %	1	18.8 %	+995.20%
Asia 4.1 %	-	-	0	4.1 %	-
Sweden 0.6 %	-	-	0	0.6 %	-

Managers	Title	Age	Since
Anders Rylander CEO	Chief Executive Officer	54	09-12-31
Anders Morén DFI	Director of Finance/CFO	59	22-12-31
Hanna Ritzen COO	Chief Operating Officer	45	21-12-31
Tomas Andersson COO	Chief Operating Officer	64	19-12-31
Joakim Arwidson LAW	General Counsel	56	20-12-31
Helle Fisker PRN	Corporate Officer/Principal	55	20-12-31
Henrik Bernhard Winther PRN	Corporate Officer/Principal	58	19-11-17

Members of the board	Title	Age	Since
Lars Erik Holmqvist CHM	Chairman	64	19-03-19
Annika Berg BRD	Director/Board Member	61	19-12-31
Maria Holmlund BRD	Director/Board Member	68	15-12-31
Jarl Ulf Birger Jungnelius BRD	Director/Board Member	73	13-12-31
Anders Rylander CEO	Chief Executive Officer	54	09-12-31
Jesper Söderqvist BRD	Director/Board Member	58	12-12-31
Henrik Osvald BRD	Director/Board Member	65	18-12-31
Marie-Louise Fjaellskog BRD	Director/Board Member	59	19-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	6,271,293	0	0	92.54 %
Stock B	1	77,784,267	77,784,267 ( 100.00 %)	0

Name	Equities	%	Valuation
Henrik Osvald 0.8534 %	663,847	0.8534 %	172 381 kr
Gunnar Rylander 0.7488 %	582,442	0.7488 %	151 243 kr
Lars Erik Holmqvist 0.7426 %	577,615	0.7426 %	149 989 kr
Andra AP-fonden 0.6495 %	505,247	0.6495 %	131 197 kr
LYM Consulting AB 0.6072 %	472,343	0.6072 %	122 653 kr
Mattias Sesemann 0.5492 %	427,189	0.5492 %	110 928 kr
Anders Rylander 0.5193 %	403,938	0.5193 %	104 891 kr

Name	Equities	%	Valuation
Anders Rylander 53.99 %	3,575,640	53.99 %	928 486 kr
Gunnar Rylander 14.43 %	955,723	14.43 %	248 173 kr
Kristina Gronowitz 6.215 %	411,660	6.215 %	106 896 kr

Biovica International AB

Dag Hammarskjölds väg 54B Uppsala Science Park

752 37, Uppsala

+46 1 84 44 48 30

http://www.biovica.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
EXACT SCIENCES CORPORATION	-37.33%	8.27B
GUARDANT HEALTH, INC.	+14.86%	3.67B
IOVANCE BIOTHERAPEUTICS, INC.	+7.38%	2.36B
BGI GENOMICS CO., LTD.	-25.96%	1.87B
VERACYTE, INC.	-17.30%	1.73B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+36.49%	1.14B
CAREDX, INC	+32.58%	823M
SEEGENE, INC.	-7.64%	678M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-18.37%	573M

Bio Diagnostics & Testing